Published in J Clin Invest on December 01, 1995
Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest (1997) 4.31
Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP. J Cell Biol (2004) 4.16
Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. J Clin Invest (2001) 2.90
Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix. Osteoarthritis Cartilage (2009) 2.65
Early detection of aging cartilage and osteoarthritis in mice and patient samples using atomic force microscopy. Nat Nanotechnol (2009) 2.19
Cyclin-dependent kinase 9 inhibition protects cartilage from the catabolic effects of proinflammatory cytokines. Arthritis Rheumatol (2014) 2.03
Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints. J Clin Invest (1997) 1.97
Mapping proteolytic cancer cell-extracellular matrix interfaces. Clin Exp Metastasis (2008) 1.83
Defining the roles of inflammatory and anabolic cytokines in cartilage metabolism. Ann Rheum Dis (2008) 1.82
Potential involvement of oxidative stress in cartilage senescence and development of osteoarthritis: oxidative stress induces chondrocyte telomere instability and downregulation of chondrocyte function. Arthritis Res Ther (2005) 1.79
Age-related changes in the musculoskeletal system and the development of osteoarthritis. Clin Geriatr Med (2010) 1.72
Evidence for altered synthesis of type II collagen in patients with osteoarthritis. J Clin Invest (1998) 1.66
Articular cartilage chondrons: form, function and failure. J Anat (1997) 1.66
Effects of aging on articular cartilage homeostasis. Bone (2012) 1.40
Why is osteoarthritis an age-related disease? Best Pract Res Clin Rheumatol (2010) 1.40
Type II collagen degradation and its regulation in articular cartilage in osteoarthritis. Ann Rheum Dis (2002) 1.36
Loss of cartilage structure, stiffness, and frictional properties in mice lacking PRG4. Arthritis Rheum (2010) 1.36
Autophagy and cartilage homeostasis mechanisms in joint health, aging and OA. Nat Rev Rheumatol (2011) 1.34
Tissue engineering of articular cartilage with biomimetic zones. Tissue Eng Part B Rev (2009) 1.30
Gene expression of matrix metalloproteinases 1, 3, and 9 by chondrocytes in osteoarthritic human knee articular cartilage is zone and grade specific. Ann Rheum Dis (1997) 1.24
Extracellular superoxide dismutase and oxidant damage in osteoarthritis. Arthritis Rheum (2005) 1.22
ISSLS prize winner: integrating theoretical and experimental methods for functional tissue engineering of the annulus fibrosus. Spine (Phila Pa 1976) (2008) 1.19
Validity of histopathological grading of articular cartilage from osteoarthritic knee joints. Ann Rheum Dis (1999) 1.16
Cartilage and meniscal T2 relaxation time as non-invasive biomarker for knee osteoarthritis and cartilage repair procedures. Osteoarthritis Cartilage (2013) 1.14
Increased matrix metalloproteinase-13 production with aging by human articular chondrocytes in response to catabolic stimuli. J Gerontol A Biol Sci Med Sci (2005) 1.13
Poroelasticity of cartilage at the nanoscale. Biophys J (2011) 1.11
Developmental mechanisms in articular cartilage degradation in osteoarthritis. Arthritis (2010) 1.10
The age-related changes in cartilage and osteoarthritis. Biomed Res Int (2013) 1.04
Urinary CTX-II levels are associated with radiographic subtypes of osteoarthritis in hip, knee, hand, and facet joints in subject with familial osteoarthritis at multiple sites: the GARP study. Ann Rheum Dis (2005) 1.04
Osteoarthritis in the XXIst century: risk factors and behaviours that influence disease onset and progression. Int J Mol Sci (2015) 1.04
Stem cells and cartilage development: complexities of a simple tissue. Stem Cells (2010) 1.02
Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis. Arthritis Res Ther (2006) 1.01
Two-dimensional strain fields on the cross-section of the bovine humeral head under contact loading. J Biomech (2008) 1.01
Targeting collagen strands by photo-triggered triple-helix hybridization. Proc Natl Acad Sci U S A (2012) 1.01
Type II collagen induces peripheral tolerance in BALB/c mice via the generation of CD8+ T regulatory cells. PLoS One (2012) 1.01
International Cartilage Repair Society (ICRS) Recommended Guidelines for Histological Endpoints for Cartilage Repair Studies in Animal Models and Clinical Trials. Cartilage (2011) 1.01
Cleavage of type II collagen by cathepsin K in human osteoarthritic cartilage. Am J Pathol (2008) 1.00
A degeneration-based hypothesis for interpreting fibrillar changes in the osteoarthritic cartilage matrix. J Anat (2001) 0.99
Eye-mediated immune tolerance to Type II collagen in arthritis-prone strains of mice. J Cell Mol Med (2014) 0.98
Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage. Am J Pathol (1997) 0.97
Fibroblast activation protein alpha is expressed by chondrocytes following a pro-inflammatory stimulus and is elevated in osteoarthritis. Arthritis Res Ther (2006) 0.97
Resistance of small leucine-rich repeat proteoglycans to proteolytic degradation during interleukin-1-stimulated cartilage catabolism. Biochem J (1999) 0.95
Procollagen II C propeptide level in the synovial fluid as a predictor of radiographic progression in early knee osteoarthritis. Ann Rheum Dis (2003) 0.95
Increased type II collagen cleavage by cathepsin K and collagenase activities with aging and osteoarthritis in human articular cartilage. Arthritis Res Ther (2012) 0.93
Collagen biomarkers for arthritis applications. Biomark Insights (2007) 0.93
Differential recovery of glycosaminoglycan after IL-1-induced degradation of bovine articular cartilage depends on degree of degradation. Arthritis Res Ther (2003) 0.91
The relationship of autophagy defects to cartilage damage during joint aging in a mouse model. Arthritis Rheumatol (2015) 0.91
Study of the collagen structure in the superficial zone and physiological state of articular cartilage using a 3D confocal imaging technique. J Orthop Surg Res (2008) 0.91
Proinflammatory Cytokines Stimulate Mitochondrial Superoxide Flashes in Articular Chondrocytes In Vitro and In Situ. PLoS One (2013) 0.90
Replacing Shox2 with human SHOX leads to congenital disc degeneration of the temporomandibular joint in mice. Cell Tissue Res (2013) 0.90
Localization of viscous behavior and shear energy dissipation in articular cartilage under dynamic shear loading. J Biomech Eng (2013) 0.90
Physical activity in relation to knee cartilage T2 progression measured with 3 T MRI over a period of 4 years: data from the Osteoarthritis Initiative. Osteoarthritis Cartilage (2013) 0.90
Inactivation of one allele of the type II collagen gene alters the collagen network in murine articular cartilage and makes cartilage softer. Ann Rheum Dis (2001) 0.89
Micromechanical mapping of early osteoarthritic changes in the pericellular matrix of human articular cartilage. Osteoarthritis Cartilage (2013) 0.89
Traversing the intact/fibrillated joint surface: a biomechanical interpretation. J Anat (2005) 0.89
Cartilage collagen damage in hip osteoarthritis similar to that seen in knee osteoarthritis; a case-control study of relationship between collagen, glycosaminoglycan and cartilage swelling. BMC Musculoskelet Disord (2013) 0.88
Amino acid racemization reveals differential protein turnover in osteoarthritic articular and meniscal cartilages. Arthritis Res Ther (2009) 0.88
Prospects for treating osteoarthritis: enzyme-protein interactions regulating matrix metalloproteinase activity. Ther Adv Chronic Dis (2012) 0.88
Expression of MMP-1 in cartilage and synovium of experimentally induced rabbit ACLT traumatic osteoarthritis: immunohistochemical study. Rheumatol Int (2008) 0.87
An in vitro model for the pathological degradation of articular cartilage in osteoarthritis. J Biomech (2013) 0.86
Characterization of helical cleavages in type II collagen generated by matrixins. Biochem J (1998) 0.86
Aggrecanases in the human synovial fluid at different stages of osteoarthritis. Clin Rheumatol (2013) 0.85
Looping mediated interaction between the promoter and 3' UTR regulates type II collagen expression in chondrocytes. PLoS One (2012) 0.85
Differences in Mammalian target of rapamycin gene expression in the peripheral blood and articular cartilages of osteoarthritic patients and disease activity. Arthritis (2013) 0.85
In situ zymographic localisation of type II collagen degrading activity in osteoarthritic human articular cartilage. Ann Rheum Dis (1999) 0.83
Boning up on autophagy: the role of autophagy in skeletal biology. Autophagy (2013) 0.82
Phenotypic characterization of epiphycan-deficient and epiphycan/biglycan double-deficient mice. Osteoarthritis Cartilage (2009) 0.82
The analgesic effect of electroacupuncture on inflammatory pain in the rat model of collagenase-induced arthritis: mediation by opioidergic receptors. Rheumatol Int (2012) 0.82
Collagen metabolism of human osteoarthritic articular cartilage as modulated by bovine collagen hydrolysates. PLoS One (2013) 0.81
Association of (-1,607) 1G/2G polymorphism of matrix metalloproteinase-1 gene with knee osteoarthritis in the Turkish population (knee osteoarthritis and MMPs gene polymorphisms). Rheumatol Int (2008) 0.81
Identification of oxytetracycline as a chondrogenic compound using a cell-based screening system. J Bone Miner Metab (2010) 0.81
A Novel Method to Simulate the Progression of Collagen Degeneration of Cartilage in the Knee: Data from the Osteoarthritis Initiative. Sci Rep (2016) 0.81
Comparison of MRI T2 relaxation changes of knee articular cartilage before and after running between young and old amateur athletes. Korean J Radiol (2012) 0.80
Epigenetics and Osteoarthritis. Genes Dis (2015) 0.80
Physical indicators of cartilage health: the relevance of compliance, thickness, swelling and fibrillar texture. J Anat (2003) 0.79
Perturbation of adhesion molecule-mediated chondrocyte-matrix interactions by 4-hydroxynonenal binding: implication in osteoarthritis pathogenesis. Arthritis Res Ther (2010) 0.79
Immunohistochemical characterization of reparative tissue present in human osteoarthritic tissue. Virchows Arch (2010) 0.78
Non-invasive and in vivo assessment of osteoarthritic articular cartilage: a review on MRI investigations. Rheumatol Int (2014) 0.78
Transthyretin deposition in articular cartilage: a novel mechanism in the pathogenesis of osteoarthritis. Arthritis Rheumatol (2015) 0.78
Association of ADAMTS5 gene polymorphisms with osteoarthritis in Chinese Han population: a community-based case-control study. Rheumatol Int (2012) 0.78
Cartilage Derived from Bone Marrow Mesenchymal Stem Cells Expresses Lubricin In Vitro and In Vivo. PLoS One (2016) 0.78
Elucidating the Molecular Composition of Cartilage by Proteomics. J Proteome Res (2016) 0.77
Development and characterization of a eukaryotic expression system for human type II procollagen. BMC Biotechnol (2015) 0.77
Chondrogenic potential of human articular chondrocytes and skeletal stem cells: a comparative study. J Biomater Appl (2014) 0.77
Increased Production of Clusterin in Biopsies of Repair Tissue following Autologous Chondrocyte Implantation. Cartilage (2013) 0.77
Cellular Senescence is a Common Characteristic Shared by Preneoplasic and Osteo-Arthritic Tissue. Open Rheumatol J (2010) 0.77
Quantitative determination of morphological and territorial structures of articular cartilage from both perpendicular and parallel sections by polarized light microscopy. Connect Tissue Res (2011) 0.77
Osteochondral Biopsy Analysis Demonstrates That BST-CarGel Treatment Improves Structural and Cellular Characteristics of Cartilage Repair Tissue Compared With Microfracture. Cartilage (2016) 0.76
Carboxymethylated chitin reduces MMP-1 expression in rabbit ACLT osteoarthritic cartilage. Ann Rheum Dis (2004) 0.76
Differential detection of type II collagen N-terminal and C-terminal denaturation epitopes in degrading cartilage. Mol Pathol (1999) 0.76
Evidence for enhanced collagen type III deposition focally in the territorial matrix of osteoarthritic hip articular cartilage. Osteoarthritis Cartilage (2016) 0.76
A novel method to detect articular chondrocyte death during early stages of osteoarthritis using a non-invasive ApoPep-1 probe. Arthritis Res Ther (2015) 0.75
Epigenetic mechanisms underlying the aberrant catabolic and anabolic activities of osteoarthritic chondrocytes. Int J Biochem Cell Biol (2015) 0.75
A biphasic finite element study on the role of the articular cartilage superficial zone in confined compression. J Biomech (2014) 0.75
Articular cartilage zonal differentiation via 3D Second-Harmonic Generation imaging microscopy. Connect Tissue Res (2015) 0.75
The effect of loading rate on the development of early damage in articular cartilage. Biomech Model Mechanobiol (2016) 0.75
Ammonium-Chloride-Potassium Lysing Buffer Treatment of Fully Differentiated Cells Increases Cell Purity and Resulting Neotissue Functional Properties. Tissue Eng Part C Methods (2016) 0.75
Inflammatory Pathways in Knee Osteoarthritis: Potential Targets for Treatment. Curr Rheumatol Rev (2015) 0.75
An overview of the role of lipid peroxidation-derived 4-hydroxynonenal in osteoarthritis. Inflamm Res (2017) 0.75
Extracellular Distribution of Collagen II and Perifibrillar Adapter Proteins in Healthy and Osteoarthritic Human Knee Joint Cartilage. J Histochem Cytochem (2017) 0.75
Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am (1971) 9.93
Epidemiology of hip and knee osteoarthritis. Epidemiol Rev (1988) 4.45
Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. Biochem J (1984) 3.81
Proteoglycan-fibrillar collagen interactions. Biochem J (1988) 3.76
Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem (1994) 3.64
Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J Clin Invest (1994) 3.30
Cartilage and diarthrodial joints as paradigms for hierarchical materials and structures. Biomaterials (1992) 3.10
The tensile properties of the cartilage of human femoral condyles related to the content of collagen and glycosaminoglycans. Biochim Biophys Acta (1973) 2.81
Correlations between stiffness and the chemical constituents of cartilage on the human femoral head. Biochim Biophys Acta (1970) 2.38
Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest (1989) 2.33
Tensile properties of human knee joint cartilage: I. Influence of ionic conditions, weight bearing, and fibrillation on the tensile modulus. J Orthop Res (1986) 2.25
Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in explants of bovine articular cartilage cultured with interleukin 1. J Clin Invest (1989) 2.20
Interaction of cartilage proteoglycans with hyaluronic acid. J Supramol Struct (1977) 1.98
Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium. Lab Invest (1992) 1.74
An immunoelectron microscope study of the organization of proteoglycan monomer, link protein, and collagen in the matrix of articular cartilage. J Cell Biol (1982) 1.60
Localization of proteoglycan monomer and link protein in the matrix of bovine articular cartilage: An immunohistochemical study. J Histochem Cytochem (1980) 1.59
Relationship between the tensile properties of articular cartilage from the human knee and age. Ann Rheum Dis (1982) 1.42
Direct evidence for active metalloproteinases mediating matrix degradation in interleukin 1-stimulated human articular cartilage. Matrix (1993) 1.42
Expression of 92-kD type IV collagenase/gelatinase (gelatinase B) in osteoarthritic cartilage and its induction in normal human articular cartilage by interleukin 1. J Clin Invest (1993) 1.36
Age-related changes in the tensile properties of human articular cartilage: a comparative study between the femoral head of the hip joint and the talus of the ankle joint. Biochim Biophys Acta (1991) 1.35
Localization of a dermatan sulfate proteoglycan (DS-PGII) in cartilage and the presence of an immunologically related species in other tissues. J Histochem Cytochem (1986) 1.26
Effects of compression on the loss of newly synthesized proteoglycans and proteins from cartilage explants. Arch Biochem Biophys (1991) 1.15
Preferential mRNA expression of prostromelysin relative to procollagenase and in situ localization in human articular cartilage. J Clin Invest (1992) 1.14
Cartilage response to mechanical force in high-density chondrocyte cultures. Arthritis Rheum (1985) 1.10
Effects of static and cyclic compressive loading on articular cartilage plugs in vitro. Arthritis Rheum (1984) 1.07
Copper-H2O2 oxidation strikingly improves silver intensification of the nickel-diaminobenzidine (Ni-DAB) end-product of the peroxidase reaction. J Histochem Cytochem (1988) 0.90
Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med (2000) 11.12
MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell (1999) 6.40
Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest (1997) 4.31
Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev (2006) 3.65
Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J Clin Invest (1994) 3.30
Cartilage and diarthrodial joints as paradigms for hierarchical materials and structures. Biomaterials (1992) 3.10
Lysolecithin and cell fusion. Nature (1970) 2.90
Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. J Clin Invest (2001) 2.90
Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochem J (1996) 2.89
The effect of elective total hip replacement on health-related quality of life. J Bone Joint Surg Am (1993) 2.85
Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation (1999) 2.73
Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev (2006) 2.59
Isolation of dermatan sulfate proteoglycans from mature bovine articular cartilages. J Biol Chem (1985) 2.39
Proteoglycans from bovine nasal cartilage. Properties of a soluble form of link protein. J Biol Chem (1979) 2.32
Are neostriatal dopamine receptors co-localized? Trends Neurosci (1993) 2.28
Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in explants of bovine articular cartilage cultured with interleukin 1. J Clin Invest (1989) 2.20
Proteoglycan-induced arthritis in BALB/c mice. Clinical features and histopathology. Arthritis Rheum (1987) 2.19
Biotinylated dextran amine as an anterograde tracer for single- and double-labeling studies. J Neurosci Methods (1992) 2.12
Studies of the articular cartilage proteoglycan aggrecan in health and osteoarthritis. Evidence for molecular heterogeneity and extensive molecular changes in disease. J Clin Invest (1992) 2.10
The Triune Brain in Evolution. Role in Paleocerebral Functions. Paul D. MacLean. Plenum, New York, 1990. xxiv, 672 pp., illus. $75. Science (1990) 2.07
Detecting gene copy number fluctuations in tumor cells by microarray analysis of genomic representations. Genome Res (2000) 1.99
Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease. N Engl J Med (1990) 1.89
Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. Osteoarthritis Cartilage (2011) 1.89
The role of soft connective tissue in the breakdown of pig articular cartilage cultivated in the presence of complement-sufficient antiserum to pig erythrocytes. II. Distribution of immunoglobulin G (IgG). Int Arch Allergy Appl Immunol (1973) 1.89
A simple and sensitive antigen retrieval method for free-floating and slide-mounted tissue sections. J Neurosci Methods (1999) 1.84
Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3). J Clin Invest (2001) 1.78
Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism. J Clin Invest (1995) 1.77
Proteoglycans in health and disease: structures and functions. Biochem J (1986) 1.75
Do birds possess homologues of mammalian primary visual, somatosensory and motor cortices? Trends Neurosci (2000) 1.75
Poverty and blindness in Pakistan: results from the Pakistan national blindness and visual impairment survey. BMJ (2007) 1.68
Evidence for altered synthesis of type II collagen in patients with osteoarthritis. J Clin Invest (1998) 1.66
Cataract prevalence, cataract surgical coverage and barriers to uptake of cataract surgical services in Pakistan: the Pakistan National Blindness and Visual Impairment Survey. Br J Ophthalmol (2007) 1.66
Immunity to cartilage proteoglycans in BALB/c mice with progressive polyarthritis and ankylosing spondylitis induced by injection of human cartilage proteoglycan. Arthritis Rheum (1987) 1.66
Identification of a hyaluronic acid-binding protein that interferes with the preparation of high-buoyant-density proteoglycan aggregates from adult human articular cartilage. Biochem J (1985) 1.62
An immunoelectron microscope study of the organization of proteoglycan monomer, link protein, and collagen in the matrix of articular cartilage. J Cell Biol (1982) 1.60
Localization of proteoglycan monomer and link protein in the matrix of bovine articular cartilage: An immunohistochemical study. J Histochem Cytochem (1980) 1.59
Changes in joint cartilage aggrecan after knee injury and in osteoarthritis. Arthritis Rheum (1999) 1.59
Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1). Arthritis Rheum (2000) 1.57
Paired cervical smears: a method of reducing the false-negative rate in population screening. Obstet Gynecol (1982) 1.56
Patient satisfaction and outcome after septic versus aseptic revision total knee arthroplasty. J Arthroplasty (2000) 1.56
Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro. Microvasc Res (1998) 1.55
p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breast. Eur J Cancer (1997) 1.54
The heterogeneity of link proteins isolated from human articular cartilage proteoglycan aggregates. J Biol Chem (1982) 1.50
Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast. European Commission Working Group on Breast Screening Pathology. Eur J Cancer (2000) 1.50
Design of a retroviral-mediated ecdysone-inducible system and its application to the expression profiling of the PTEN tumor suppressor. Proc Natl Acad Sci U S A (2001) 1.49
Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis. J Exp Med (1999) 1.49
Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase. Arthritis Rheum (2000) 1.47
Differences in secretion of the proteinase cathepsin B at the edges of human breast carcinomas and fibroadenomas. Nature (1978) 1.47
Age-related changes in the structure of proteoglycan link proteins present in normal human articular cartilage. Biochem J (1983) 1.46
Direct evidence for active metalloproteinases mediating matrix degradation in interleukin 1-stimulated human articular cartilage. Matrix (1993) 1.42
The immunologic detection and characterization of cartilage proteoglycan degradation products in synovial fluids of patients with arthritis. Arthritis Rheum (1987) 1.41
Subsequent bilateral occurrence of fibrous breast tumors; a case report. Eur J Radiol (1991) 1.39
Identification of core protein, an intermediate in proteoglycan biosynthesis in cultured chondrocytes from the Swarm rat chondrosarcoma. J Biol Chem (1981) 1.35
Characterization of a thiol proteinase secreted by malignant human breast tumours. Biochim Biophys Acta (1980) 1.33
Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease. Ann Neurol (1992) 1.31
Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. Eur J Cancer (2003) 1.31
An analysis of 14 molecular markers for monitoring osteoarthritis: segregation of the markers into clusters and distinguishing osteoarthritis at baseline. Osteoarthritis Cartilage (2000) 1.29
Immunoinhibition of intracellular protein digestion in macrophages. J Exp Med (1973) 1.29
Striatal and nigral neuron subpopulations in rigid Huntington's disease: implications for the functional anatomy of chorea and rigidity-akinesia. Ann Neurol (1990) 1.29
Association of an extracellular protein (chondrocalcin) with the calcification of cartilage in endochondral bone formation. J Cell Biol (1984) 1.28
Action of concanavalin A on the attachment stage of phagocytosis by macrophages. Exp Cell Res (1971) 1.28
Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev (2005) 1.28
Differential loss of striatal projection systems in Huntington's disease: a quantitative immunohistochemical study. J Chem Neuroanat (2004) 1.27
Localization of a dermatan sulfate proteoglycan (DS-PGII) in cartilage and the presence of an immunologically related species in other tissues. J Histochem Cytochem (1986) 1.26
Secretion of proteinases from malignant and nonmalignant human breast tissue. Cancer Res (1980) 1.25
Role of proteoglycans in endochondral ossification: immunofluorescent localization of link protein and proteoglycan monomer in bovine fetal epiphyseal growth plate. J Cell Biol (1982) 1.25
Proteoglycans from bovine nasal cartilage. Immunochemical studies of link protein. J Biol Chem (1980) 1.24
Age-related changes in protein-related epitopes of human articular-cartilage proteoglycans. Biochem J (1986) 1.24
Altered distribution of lysosomal cathepsin D in ischemic myocardium. J Clin Invest (1977) 1.21
The extracellular matrix of cartilage in the growth plate before and during calcification: changes in composition and degradation of type II collagen. Calcif Tissue Int (1992) 1.21
The Ranawat Award. Comparison of surgical approaches in total knee arthroplasty. Clin Orthop Relat Res (1998) 1.20
Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology. J Clin Pathol (2004) 1.19
Consistency of staining and reporting of oestrogen receptor immunocytochemistry within the European Union--an inter-laboratory study. Virchows Arch (2004) 1.19
CAG repeat lengths > or =335 attenuate the phenotype in the R6/2 Huntington's disease transgenic mouse. Neurobiol Dis (2008) 1.19
Extracellular presence of the lysosomal proteinase cathepsin B in rheumatoid synovium and its activity at neutral pH. Arthritis Rheum (1984) 1.17